GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT

This adverse event was reported 2130 times

These drugs are most commonly taken by patients reporting GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT:

# Drug Count
0 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 791
1 MYCOPHENOLATE MOFETIL 790
2 TACROLIMUS 701
3 FLUDARABINE PHOSPHATE 691
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 648
5 TACROLIMUS OINTMENT 0.1% 647
6 CYCLOSPORINE 638
7 METHOTREXATE SODIUM 540
8 METHOTREXATE 495
9 CYCLOPHOSPHAMIDE 485
See all common drugs associated with GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT

GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREOSULFAN 134 0.0486
1 THIOTEPA 246 0.0252
2 BUSULFAN 354 0.0222
3 FLUDARABINE PHOSPHATE 691 0.0173
4 DEFIBROTIDE SODIUM 50 0.0140
5 FOSCARNET SODIUM 47 0.0117
6 SIROLIMUS 111 0.0081
7 MELPHALAN HYDROCHLORIDE 199 0.0079
8 ALEMTUZUMAB 151 0.0078
9 VANCOMYCIN HYDROCHLORIDE 63 0.0075
See all drugs enriched for association with GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT